From: The role of human papillomavirus in head and neck cancer in Senegal
Variables | Cases tested for HPV | HPV positive cases | ||
---|---|---|---|---|
N | % | N | % (95% CI) | |
Gender | ||||
Male | 83 | 70.9 | 1 | 1.2 (0.0-6.5) |
Female | 34 | 29.1 | 3 | 8.8 (1.9-23.4) |
Age at diagnosis (in years) | ||||
≤ 39 | 28 | 23.9 | 1 | 3.6 (0.0-18.3) |
40-49 | 16 | 13.7 | 1 | 6.2 (0.2-30.2) |
50-59 | 19 | 16.2 | 0 | 0.0 (0.0-17.6)b |
≥ 60 | 49 | 41.9 | 2 | 4.1 (0.5-14.0) |
Missing | 5 | 4.3 | 0 | 0.0 (0.0-52.2)b |
Period of diagnosis | ||||
2002 - 2008 | 53 | 45.3 | 3 | 5.7 (1.2-15.7) |
2009 - 2010 | 64 | 54.7 | 1 | 1.6 (0.0-8.4) |
Histological type | ||||
Squamous cell carcinoma | 112 | 95.7 | 4 | 3.6 (1.0-8.9) |
Adenocarcinoma | 1 | 0.9 | 0 | 0.0 (0.0-97.5)b |
Other diagnosesa | 4 | 3.4 | 0 | 0.0 (0.0-60.2)b |
Total | 117 | 100 | 4 | 3.4 (0.9-8.5) |